Previous Next Low-value Care Gilead’s Remdesivir Can Hardly Live Up to the Hype Abstract: Reports of success in a Chicago trial suggest the drug has promise, not that it works. Publication: Bloomberg Date Published: April 17, 2020 Author(s): Max Nisen View This Resource